Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.

Take advantage of this offer from
CBD Science Group PLC.

Capital at risk. *Tax relief depends on individual circumstances and may be subject to change.

Share Purchase

To calculate the number of shares you will get, please enter your desired investment amount below.

Investment Amount:

Share Price

Total Number of Shares 
(Investment / Share Price)

Potential EIS Saving*

Business Strategy

  • Helping Cancer Patients with Chronic Pain
    • 3,000,000 people are currently suffering from cancer in the UK, with 1000 patients diagnosed daily
    • 33% of those who suffer from pain associated with cancer are undertreated

  • CBD Science Group PLC has identified this unmet medical need and has initiated Real World Evidence (RWE) clinical study.

  • Creating Shareholder Value
    • Every 1000 patients treated has the potential to generate £3.6 million in annual revenue for CBD Science Group PLC.
    • Comparable companies are trading at 10 to 40 times revenue.

  • Market Potential
    • UK Medicinal Cannabis market forecasted value of £7.7 Billion by 2028
    • 1.4 million Briton's are using cannabinoids to treat their illnesses
    • GW Pharma, the largest UK based cannabinoid company, as a comparable, has a market valuation close to £5.3 billion


Our RWE study will be on patients already being treated with pain medicines, eg Opioids, which do not work or are inappropriate for many thousands of patients. Our unique blend of cannabis-based medicine will treat these patients to alleviate this pain and continuing suffering in this RWE study over a four-month period.
The patients recruited into the RWE study will have an individual agreement with each hospital to ensure that the NHS pays for these patients at the end of the 4-month study. These results, together with a publication will add value to the shareholders.
Crowd for Angels is an FCA regulated UK crowdfunding platform that raises funds for companies through the issue of shares and crowd bonds to investors in a tax efficient manner. We have helped raise several million pounds for UK companies and continue to help companies through their growth cycle.
If you choose to invest, please visit the CBD Science Group PLC pitch and click 'Invest Now' you will be taken through a series of steps, including registration, KYC check and Payment. You can pay via bank transfer, debit card and digital currencies.
We do not charge investors a fee.

What to know more?
Introducing CBD Science Group | Graeme Mcfarlane, Chief Commercial Officer

Capital at risk. Tax relief depends on individual circumstances and may be subject to change.

To join the crowd fill out this form

First Name*
Last Name*
I Reside In*

Haven't answered your question?

Then get in touch with one of our professional team using

Risk Warning

Investment Risks

Investing in small public listed or private companies involves many risks, including illiquidity, lack of dividends, loss of investment and equity dilution. It should be done only as part of a diversified portfolio. Investing in debt pitches through Crowd for Angels (UK) Limited involves lending to companies and therefore your capital is at risk and interest payments are not guaranteed if the borrower defaults. Please click here to read the full Risk Warning.

Investor Suitability

Investments on this website are targeted exclusively at investors who are sufficiently sophisticated to understand the risks involved and make their own investment decisions. You will only be able to invest in pitches on this website once you are fully authorised and the investment is deemed appropriate for you.

Basis of Investment

Investments can only be made on the basis of information provided in pitches by the investee companies concerned. Crowd for Angels takes no responsibility for information provided by external sources, including investee company websites.

Forward Looking Statements & Forecasts

Pitches may contain forward looking statements and financial forecasts or projections. Forecasts are not a reliable indicator of future performance. Crowd for Angels makes no judgement or opinion of the likelihood of targets being achieved. 

Lack of FSCS Protection

Investments made in companies listed on the Crowd for Angels platform are not covered by the Financial Services Compensation Scheme (FSCS).

Tax Relief

The availability of any tax relief, including EIS and SEIS, depends on the individual circumstances of each investor and of the company concerned, and may be subject to change in the future. If you are in any doubt about the availability of any tax reliefs, or the tax treatment of your investment, you should obtain independent tax advice before proceeding with your investment.

Innovative Finance ISA

Holding an investment within an innovative finance ISA does not reduce the risks associated with an investment or guarantee returns and it is possible to lose all of the money invested.

This page has been approved as a Financial Promotion by Crowd for Angels (UK) Limited (Company number: 03064807), which is authorised and regulated by the Financial Conduct Authority (Reference number: 176508).